Oncotarget

In The News



Small RNA molecules trigger cancer cells to commit suicide


2017-10-20
Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules to trigger a fail-safe mechanism that may protect us from cancer. The mechanism -- RNA suicide molecules -- can potentially be developed into a novel form of cancer therapy, the study authors said. Cancer cells treated with the RNA molecules never become resistant ...continue reading >>


Suicide molecules kill any cancer cell


2017-10-19
Suicide molecules kill any cancer cell October 19, 2017 Credit: CC0 Public Domain Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules to trigger a fail-safe mechanism that may protect us from cancer. The mechanism—RNA suicide molecules—can potentially be developed into a novel form of cancer therapy, the study auth ...continue reading >>


MTSU Researchers Take Aim at Metastatic Breast Cancer


2017-10-19
MTSU Researchers Take Aim at Metastatic Breast Cancer Article ID: 683422 CHANNELS Breast Cancer , Botanical Drug , Middle Tennessee State University , Tennessee Center for Botanical Medicine Research Newswise — MURFREESBORO, Tenn. — Middle Tennessee State University faculty, students and funding are playing a crucial role in breakthrough research aimed at helping treat metastatic breast cancer. New hope for a low-toxic treatment of this cancer has been reported in the prestigious resea ...continue reading >>


Breast cancer researchers find bacteria imbalance link


2017-10-19
Charis Eng, M.D., Ph.D., chair of the Cleveland Clinic's Genomic Medicine Institute. Credit: Cleveland Clinic Researchers The team learned that healthy breast tissue contains more of the bacterial species Methylobacterium, a finding that could offer a new perspective in the battle against breast cancer , which caused 571,000 deaths in 2015 and is the top cancer in women globally, according to the World Health Organization. Bacteria that live in the body, known as the microbiome, influence ...continue reading >>


Suicide molecules kill any cancer cell


2017-10-19
Suicide molecules kill any cancer cell Time traveling hundreds of millions of years to unleash one of nature's original kill switches Northwestern University Super assassin in every cell is poised to take out cancer cells Cancer cells treated with certain human RNA molecules never become resistant to them Kill mechanism likely predates immune system by hundreds of millions of years 'It's like committing suicide by stabbing yourself, shooting yourself and jumping off a building' CHICAGO --- Sma ...continue reading >>


Cannabis is Also a Powerful Preventative Medicine | Alternative


2017-10-18
(Before It's News) Anna Hunt , Staff Writer Waking Times Most doctors no longer contend the medicinal value of cannabis, as there are hundreds of scientific studies that prove it, making the point difficult to argue. Furthermore, pharmaceutical companies are developing cannabinoid-based medicines, affirming that cannabis benefits the human body. It is these substances – cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) – which give the cannabis plant its medicinal propert ...continue reading >>


Cannabis is Also a Powerful Preventative Medicine


2017-10-18
Cannabis is Also a Powerful Preventative Medicine October 18, 2017 Waking Times Most doctors no longer contend the medicinal value of cannabis, as there are hundreds of scientific studies that prove it, making the point difficult to argue. Furthermore, pharmaceutical companies are developing cannabinoid-based medicines, affirming that cannabis benefits the human body. It is these substances – cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) – which give the cannabis pl ...continue reading >>


Biology of Childhood Brain Tumor Subtypes Offers Clues to Precision Treatments


2017-10-17
Printer friendly page (HealthNewsDigest.com) - Philadelphia, – Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer. By shedding light on subtle distinctions in tumor biology, these findings offer clues to designing more effective anticancer treatments to precisely target tumors in individual patients. “Carefully def ...continue reading >>


Drinking several cups of tea a day could PROTECT you against CANCER


2017-10-17
Food that can increase risk of bowel cancer GETTY Cancer diet: Regularly drinking tea could reduce risk of ovarian cancer Dr Catherine Hood, from the Tea Advisory Panel, said: “Cancer risk reduced by 4% for every cup of tea drunk, especially in women.” A further study, also published in Oncotarget, showed that the highest tea drinkers had a seven per cent reduced risk of bowel cancer. “The effects were strongest in women and those who drank green tea,” said Dr Hood of the findings. F ...continue reading >>


Biology of childhood brain tumour subtypes offers clues to precision treatments


2017-10-17
Biology of childhood brain tumour subtypes offers clues to precision treatments 17 Oct 2017 Researchers investigating paediatric low-grade gliomas (PLGG), the most common type of brain tumour in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer. By shedding light on subtle distinctions in tumour biology, these findings offer clues to designing more effective anticancer treatments to precisely target tumours in indi ...continue reading >>


Biology of childhood brain tumor subtypes offers clues to precision treatments


2017-10-17
Biology of childhood brain tumor subtypes offers clues to precision treatments October 17, 2017 Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer. By shedding light on subtle distinctions in tumor biology, these findings offer clues to designing more effective anticancer treatments to precisely target tumors in indiv ...continue reading >>


CHOP researchers discover key differences among gene fusions in childhood brain tumors


2017-10-17
Download PDF Copy October 17, 2017 Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood cancer. By shedding light on subtle distinctions in tumor biology, these findings offer clues to designing more effective anticancer treatments to precisely target tumors in individual patients. "Carefully defining the molecular landscape ...continue reading >>


Biology of Childhood Brain Tumor Subtypes Offers Clues to Precision Treatments


2017-10-17
Biology of Childhood Brain Tumor Subtypes Offers Clues to Precision Treatments CHOP Researchers Reveal Differences among Gene Fusions in Low-Grade Pediatric Brain Tumors Article ID: 683137 Available for logged-in reporters only CITATIONS NS085336, TR000138; Oncogene, online Aug. 14, 2017 ; Oncotarget, online Sept. 15, 2017 CHANNELS + Show More Newswise — Philadelphia, Oct. 16, 2017 – Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in chil ...continue reading >>


Breast Cancer Linked to Bacterial Imbalances


2017-10-14
Breast Cancer Linked to Bacterial Imbalances 3444 Bacteria that live in the body, known as the microbiome, influence many diseases. Most research has been done on the “gut” microbiome, or bacteria in the digestive tract. Researchers have long suspected that a “microbiome” exists within breast tissue and plays a role in breast cancer but it has not yet been characterized. In a newly published study, Cleveland Clinic researchers have uncovered differences in the bacterial composition of b ...continue reading >>


NantKwest, NantCell, And Dr. Soon-Shiong's 2020 Cancer Vision


2017-10-11
Long only, biotech, Growth, contrarian Summary Controversial cancer figure Dr. Patrick Soon-Shiong is rapidly gathering a hotbed of some of the very best and lesser known anti-cancer agent candidates engaged in and/or completing clinical trials. Proprietary platform to develop modified activated natural killer cells may be the "Holy Grail" of chimeric antigen receptor technology (CAR-T) to treat some cancers. Revolutionary approach to treat cancer as a chronic disease with newer and safer nex ...continue reading >>


Life Extension Daily News


2017-10-10
and director of the Center for Personalized Genetic Healthcare . "Our hope is to find a biomarker that would help us diagnose breast cancer quickly and easily. In our wildest dreams, we hope we can use microbiomics right before breast cancer forms and then prevent cancer with probiotics or antibiotics." Published online in Oncotarget on Oct. 5, 2017 , the study examined the tissues of 78 patients who underwent mastectomy for invasive carcinoma or elective cosmetic breast surgery. In addition, ...continue reading >>


Researchers Find Link Between Bacterial Imbalances and Breast Cancer


2017-10-09
Researchers Find Link Between Bacterial Imbalances and Breast Cancer Mon, 10/09/2017 - 2:50pm Comments by Cleveland Clinic In a newly published study, Cleveland Clinic researchers have uncovered differences in the bacterial composition of breast tissue of healthy women vs. women with breast cancer. The research team has discovered for the first time that healthy breast tissue contains more of the bacterial species Methylobacterium, a finding which could offer a new perspective in the battle aga ...continue reading >>


IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer


2017-10-09
Undiscovered Managers Home > IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colore ...continue reading >>


IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic


2017-10-09
IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer Monday, 9 October 2017 ( 1 hour ago ) ÉVRY, France--(BUSINESS WIRE)--Regulatory News: IntegraGen (Paris:ALINT), a company specializing in the transformation of data from biological samples into genomic information and diagnostic tools for oncology, today announced that results from an analysis of miR-31-3p expression in tumor samples fr ...continue reading >>


Cleveland Clinic Researchers Find Link Between Bacterial Imbalances and Breast Cancer


2017-10-09
Cleveland Clinic Researchers Find Link Between Bacterial Imbalances and Breast Cancer Study compares bacterial composition in healthy vs. cancerous breast tissue October 5, 2017 / News Releases Share Twitter In a newly published study, Cleveland Clinic researchers have uncovered differences in the bacterial composition of breast tissue of healthy women vs. women with breast cancer. The research team has discovered for the first time that healthy breast tissue contains more of the bacterial spec ...continue reading >>


IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer


2017-10-09
ÉVRY, France- Regulatory News: IntegraGen (Paris:ALINT), a company specializing in the transformation of data from biological samples into genomic information and diagnostic tools for oncology, today announced that results from an analysis of miR-31-3p expression in tumor samples from patients enrolled in the NEW EPOC clinical trial have been published online in Oncotarget. The paper entitled “Association between miR-31- 3p expression and cetuximab efficacy in patients with KRAS wild-type met ...continue reading >>


IntegraGen : announces miR-31-3p publication in Oncotarget | 4-Traders


2017-10-09
IntegraGen announces that results from an analysis of miR-31-3p expression in tumor samples from patients enrolled in the NEW EPOC clinical trial have been published online in Oncotarget . The paper entitled 'Association between miR-31- 3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial' confirms the relationship between miR-31-3p expression and the efficacy of anti-EGFR treatment. Click here to view press ...continue reading >>


IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer


2017-10-09
IntegraGen Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer Regulatory News: IntegraGen (Paris:ALINT), a company specializing in the transformation of data from biological samples into genomic information and diagnostic tools for oncology, today announced that results from an analysis of miR-31-3p expression in tumor samples from patients enrolled in the NEW EPOC clinical trial have been publishe ...continue reading >>


IntegraGen : Announces Publication in Oncotarget Showing Association of miR-31-3p Expression Levels with Progression-Free Survival in Metastatic Colorectal Cancer | 4-Traders


2017-10-09
Regulatory News: IntegraGen (Paris:ALINT), a company specializing in the transformation of data from biological samples into genomic information and diagnostic tools for oncology, today announced that results from an analysis of miR-31-3p expression in tumor samples from patients enrolled in the NEW EPOC clinical trial have been published online in Oncotarget. The paper entitled “Association between miR-31- 3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colore ...continue reading >>


IntegraGen announces miR-31-3p publication in Oncotarget


2017-10-09
IntegraGen announces that results from an analysis of miR-31-3p expression in tumor samples from patients enrolled in the NEW EPOC clinical trial have been published online in Oncotarget. The paper entitled ' Association between miR-31- 3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic


Breast Cancer Linked to Bacterial Imbalances


2017-10-08
13 Breast Cancer Linked to Bacterial Imbalances Tweet TEHRAN (FNA)- Researchers uncovered differences in the bacterial composition of breast tissue of healthy women vs. women with breast cancer. The research team has discovered for the first time that healthy breast tissue contains more of the bacterial species Methylobacterium, a finding which could offer a new perspective in the battle against breast cancer. Bacteria that live in the body, known as the microbiome, influence many diseases. Mos ...continue reading >>


Cleveland Clinic Researchers Find Link Between Bacterial Imbalances And Breast Cancer


2017-10-08
Cleveland Clinic Researchers Find Link… Cleveland Clinic October 5, 2017, Cleveland: In a newly published study, Cleveland Clinic researchers have uncovered differences in the bacterial composition of breast tissue of healthy women vs. women with breast cancer. The research team has discovered for the first time that healthy breast tissue contains more of the bacterial species Methylobacterium, a finding which could offer a new perspective in the battle against breast cancer. Bacteria th ...continue reading >>


Researchers find link between bacterial imbalances and breast cancer


2017-10-06
Researchers find link between bacterial imbalances and breast cancer October 6, 2017 Micrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/Wikipedia In a newly published study, Cleveland Clinic researchers have uncovered differences in the bacterial composition of breast tissue of healthy women vs. women with breast cancer. The research team has discovered for the first time that healthy breast tissue contains mor ...continue reading >>


Cleveland Clinic researchers find link between bacterial imbalances and breast cancer


2017-10-06
Cleveland Clinic researchers find link between bacterial imbalances and breast cancer Study compares bacterial composition in healthy vs. cancerous breast tissue Cleveland Clinic Print E-Mail October 5, 2017, Cleveland: In a newly published study, Cleveland Clinic researchers have uncovered differences in the bacterial composition of breast tissue of healthy women vs. women with breast cancer. The research team has discovered for the first time that healthy breast tissue contains more of the ba ...continue reading >>


Novel drug combo for triplenegative breast cancer


2017-10-03
[Articles] Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial In this work, the University of Michigan researchers tested drugs separately in triple-negative breast cancer cell lines and in mice with the disease. They then implemented the treatments together. Preliminary data had shown that inhibiting proteins called cyclin-dependent kin ...continue reading >>


Novel drug combo for triple-negative breast cancer


2017-10-02
Novel drug combo for triple-negative breast cancer By In the hunt for novel treatments against triple-negative breast cancer, US researchers have combined a new protein inhibitor with a chemotherapy drug. In this work, researchers tested drugs separately in triple-negative breast cancer cell lines and in mice with the disease. They then implemented the treatments together. Preliminary data had shown that inhibiting proteins called cyclin-dependent kinases, or CDKs, might be effective agai ...continue reading >>


MTSU breast cancer researchers play crucial role in breakthrough treatments


2017-10-01
CLOSE Watch the video to learn about breast cancer symptoms that aren't lumps. Time Visiting Chinese scholar Li Chen, left, assists as lead researcher Iris Gao prepares a sample of DMDD powder to make the solution used in breast cancer research at MTSU. (Photo: J. Intintoli, Middle Tennessee State Universit) CONNECT 1 COMMENT EMAIL MORE The root of the star fruit tree is taking center stage in treating metastatic breast cancer . And Middle Tennessee State University faculty, students and funding ...continue reading >>


Individuals in the US Diagnosed with Cancer are 2.7 Times More Likely to Declare Bankruptcy Than Individuals Without Cancer, Study Finds


2017-09-29
ORCHARD PARK, N.Y.- As advancements in cancer therapies have been making headlines in recent years, cancer drug prices have significantly increased. The remaining question is, what are the economic impacts of the differentiations in cost of FDA approved drugs and the purchasing power of individuals around the world? This study , published in Oncotarget, titled “A global comparison of the cost of patented cancer drugs in relation to global differences in wealth ” identifies several critical f ...continue reading >>


Individuals In The US Diagnosed With Cancer Are 2.7 Times More Likely To Declare Bankruptcy Than Individuals Without Cancer, Study Finds, Published In /i>


2017-09-29
View More Jobs An audio version of this research article is also available online ORCHARD PARK, N.Y.--( BUSINESS WIRE )--As advancements in cancer therapies have been making headlines in recent years, cancer drug prices have significantly increased. The remaining question is, what are the economic impacts of the differentiations in cost of FDA approved drugs and the purchasing power of individuals around the world? This study , published in Oncotarget, titled “A global comparison of the cost ...continue reading >>


Individuals in the US Diagnosed with Cancer are 2.7 Times More Likely to Declare Bankruptcy Than Individuals Without Cancer, Study Finds


2017-09-29
Individuals in the US Diagnosed with Cancer are 2.7 Times More Likely to Declare Bankruptcy Than Individuals Without Cancer, Study Finds 28 Sep, 2017 Tweet As advancements in cancer therapies have been making headlines in recent years, cancer drug prices have significantly increased. The remaining question is, what are the economic impacts of the differentiations in cost of FDA approved drugs and the purchasing power of individuals around the world? This study, published in Oncotarget, titled ...continue reading >>


Switch That May Help Target Dormant Cancer Cells Identified


2017-09-28
Switch That May Help Target Dormant Cancer Cells Identified Thu, 09/28/2017 - 11:13am Comments by Galus J. Augustus, University of Arizona A study by scientists at the University of Arizona and the University of Pittsburgh may hold the key to targeting dormant — or inactive —cancer cells, which are resistant to chemotherapy and other treatments. The results were published in the journal Cell Reports. Cells can enter a sleeplike state known as quiescence, during which they stop growing and ...continue reading >>


Winchester, Breaking News, Decherd, Sewanee, Monteagle, Lynchburg, Tims Ford, Tullahoma, Cowan, Bonnaroo, Manchester, Motlow, Franklin County, Belvidere, Huntland in Tennessee,TN, Sign Dept.


2017-09-28
MTSU researchers take aim at metastatic breast cancer Posted on Wednesday, September 27, 2017 at 12:07 pm Lead researcher Iris Gao, left, and graduate student Nadin Almosnid document their findings regarding metastatic breast cancer cells in the tissue culture teaching lab inside the Science Building. (MTSU photo by J. Intintoli) MTSU graduate student Gheda Alsaif, foreground, and visiting Chinese scholar Li Chen take a culture of the human vascular cells in the lab. (MTSU photo by J. Intintoli ...continue reading >>


Individuals in the US Diagnosed with Cancer are 2.7 Times More Likely to Declare Bankruptcy Than Individuals Without Cancer, Study Finds


2017-09-28
An audio version of this research article is also available online As advancements in cancer therapies have been making headlines in recent years, cancer drug prices have significantly increased. The remaining question is, what are the economic impacts of the differentiations in cost of FDA approved drugs and the purchasing power of individuals around the world? This study , published in Oncotarget, titled “A global comparison of the cost of patented cancer drugs in relation to global differe ...continue reading >>


Drug Combo Gangs Up to Take on Triple-Negative Breast Cancer


2017-09-27
ANN ARBOR, Michigan — In the hunt for novel treatments against an aggressive form of breast cancer, researchers combined a new protein inhibitor with a chemotherapy drug to create a powerful combination that resulted in cancer cell death. Triple-negative breast cancer is a subtype that does not express hormone receptor or HER2. It occurs in approximately 15 percent of patients with breast cancer. This subtype tends to be more aggressive and targeted therapeutic treatment options are lacking ...continue reading >>


Drug combination shows promise against triple-negative breast cancer


2017-09-27
Drug combination shows promise against triple-negative breast cancer 27 Sep 2017 In the hunt for novel treatments against an aggressive form of breast cancer, researchers combined a new protein inhibitor with a chemotherapy drug to create a powerful combination that resulted in cancer cell death. Triple-negative breast cancer is a subtype that does not express hormone receptor or HER2. It occurs in approximately 15 percent of patients with breast cancer. This subtype tends to be more aggress ...continue reading >>


Drug Combo Gangs Up to Take on Triple-negative Breast Cancer


2017-09-27
Drug Combo Gangs Up to… Michigan Medicine – University of Michigan Society of Surgical Oncology, National Institutes of Health, A Sister’s Hope Foundation, Saslow Family ANN ARBOR, Michigan — In the hunt for novel treatments against an aggressive form of breast cancer, researchers combined a new protein inhibitor with a chemotherapy drug to create a powerful combination that resulted in cancer cell death. This is Jacqueline Jeruss, M.D., Ph.D. Credit: University of Michigan Compre ...continue reading >>


UA Cancer Center Team Identifies a Switch That May Help Target Dormant Cancer Cells


2017-09-27
UA Cancer Center Team Identifies… University of Arizona Health Sciences TUCSON, Ariz. – A study by scientists at the University of Arizona and the University of Pittsburgh may hold the key to targeting dormant — or inactive –cancer cells, which are resistant to chemotherapy and other treatments. The results were published today in the journal Cell Reports. Members of Dr. Yao´s lab, from the left: Kimiko Della Croce, Xia Wang, Nick Everetts, Guang Yao, Matt Miller, Sarah Kwon, Kota ...continue reading >>


Powerful drug combo gangs up to tackle triple-negative breast cancer


2017-09-26
Powerful drug combo gangs up to tackle triple-negative breast cancer September 26, 2017 Jacqueline Jeruss, M.D., Ph.D., in the lab. Credit: University of Michigan Comprehensive Cancer Center In the hunt for novel treatments against an aggressive form of breast cancer, researchers combined a new protein inhibitor with a chemotherapy drug to create a powerful combination that resulted in cancer cell death. Triple-negative breast cancer is a subtype that does not express hormone receptor or HER2. ...continue reading >>


Switch that may help target dormant cancer cells identified


2017-09-26
Switch that may help target dormant cancer cells identified 26 Sep 2017 A study by scientists at the University of Arizona and the University of Pittsburgh may hold the key to targeting dormant -- or inactive --cancer cells, which are resistant to chemotherapy and other treatments. The results were published today in the journal Cell Reports. Cells can enter a sleeplike state known as quiescence, during which they stop growing and dividing. Just as sleep can be deep or shallow, a cell's quie ...continue reading >>


Team identifies a switch that may help target dormant cancer cells


2017-09-26
Team identifies a switch that may help target dormant cancer cells September 26, 2017 Cancer cells. Credit: Dr. Cecil Fox, National Cancer Institute A study by scientists at the University of Arizona and the University of Pittsburgh may hold the key to targeting dormant—or inactive —cancer cells, which are resistant to chemotherapy and other treatments. The results were published today in the journal Cell Reports . Cells can enter a sleeplike state known as quiescence , during which they s ...continue reading >>


UA Cancer Center team identifies a switch that may help target dormant cancer cells


2017-09-26
September 26, 2017 TUCSON, Ariz. - A study by scientists at the University of Arizona and the University of Pittsburgh may hold the key to targeting dormant -- or inactive --cancer cells, which are resistant to chemotherapy and other treatments. The results were published today in the journal Cell Reports.Cells can enter a sleeplike state known as quiescence, during which they stop growing and dividing. Just as sleep can be deep or shallow, a cell's quiescence also can vary in depth. Altering th ...continue reading >>


Drug combo gangs up to take on triple-negative breast cancer


2017-09-26
September 26, 2017 Society of Surgical Oncology, National Institutes of Health, A Sister's Hope Foundation, Saslow Family ANN ARBOR, Michigan -- In the hunt for novel treatments against an aggressive form of breast cancer, researchers combined a new protein inhibitor with a chemotherapy drug to create a powerful combination that resulted in cancer cell death.Triple-negative breast cancer is a subtype that does not express hormone receptor or HER2. It occurs in approximately 15 percent of patient ...continue reading >>


UA Cancer Center team identifies a switch that may help target dormant cancer cells


2017-09-26
UA Cancer Center team identifies a switch that may help target dormant cancer cells University of Arizona Health Sciences IMAGE: These are cancer cells. view more Credit: Dr. Cecil Fox, National Cancer Institute TUCSON, Ariz. - A study by scientists at the University of Arizona and the University of Pittsburgh may hold the key to targeting dormant -- or inactive --cancer cells, which are resistant to chemotherapy and other treatments. The results were published today in the journal Cell Report ...continue reading >>


Drug combo gangs up to take on triple-negative breast cancer


2017-09-26
Drug combo gangs up to take on triple-negative breast cancer Researchers find novel combination disrupts multiple factors in aggressive type of cancer Michigan Medicine - University of Michigan IMAGE: This is Jacqueline Jeruss, M.D., Ph.D., in the lab. view more Credit: University of Michigan Comprehensive Cancer Center Society of Surgical Oncology, National Institutes of Health, A Sister's Hope Foundation, Saslow Family ANN ARBOR, Michigan -- In the hunt for novel treatments against an aggres ...continue reading >>


Drugs containing atorvastatin may help fight cancer and HIV, study shows


2017-09-22
Drugs containing atorvastatin may help fight cancer and HIV, study shows Posted 2 days ago Early-stage UAlberta research suggests that taking a cholesterol-lowering statin regularly may help boost the body’s ability to fight off chronic conditions like HIV and cancer. “We concluded that atorvastatin (marketed under Lipitor, among other brands) may be beneficial to patients with HIV and cancer by preventing their T-cells—a type of white blood cell that kills cancer cells or other cells in ...continue reading >>


Study shows Lipitor may help fight cancer


2017-09-20
Study shows Lipitor may help fight cancer Posted Yesterday Early-stage UAlberta research suggests that taking a cholesterol-lowering statin regularly may help boost the body’s ability to fight off chronic conditions like HIV and cancer. “We concluded that Atorvastatin (marketed under Lipitor, among other names) may be of benefit to patients with HIV and cancer by preventing their T-cells—a type of white blood cell that kills cancer cells or other cells infected with viruses—from shutting ...continue reading >>


Drugs containing atorvastatin may help fight cancer and HIV, study shows


2017-09-20
Drugs containing atorvastatin may help fight cancer and HIV, study shows Researchers find cholesterol-lowering statins boost our cancer-killing T-cells. Researchers in Shokrollah Elahi's lab found cholesterol-lowering drugs may also be of benefit to patients with HIV and cancer. (File photo) By LESLEY YOUNG Early-stage UAlberta research suggests that taking a cholesterol-lowering statin regularly may help boost the body’s ability to fight off chronic conditions like HIV and cancer. “We co ...continue reading >>



Copyright © 2017 Impact Journals
Impact Journals is a registered trademark of Impact Journals, LLC